Aktiesnakken — Januar 2011
-
lidt sjov at de kan bogføre det hele i år 1
-
mens genmab sprede det ud over 5-6 år
-
det har ret stor betydning for alk, sådan ret regnskabsmæssig
-
så mangler vi bare merck news!
-
Thure: enig i H1N1..man har hentet nogle gevinster på benefits - kan nok ikke gentages tænker jeg. det beløb til 0.40 USD per share
-
-
Morgen
-
morgen
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind